Key Insights
The Point of Care Testing (POCT) industry is poised for substantial growth, projected to reach $3.67 billion in 2025, with an impressive Compound Annual Growth Rate (CAGR) of 8.77% during the forecast period of 2025-2033. This expansion is primarily driven by the increasing prevalence of infectious diseases, the burgeoning oncology and hematology sectors demanding rapid diagnostics, and the growing adoption of prenatal testing for early detection of genetic abnormalities. Furthermore, the endocrinology segment is also contributing significantly due to the rising incidence of chronic conditions like diabetes requiring continuous monitoring. The shift towards personalized medicine and the demand for faster, more accurate results at the patient's bedside are key catalysts. The technology landscape is evolving rapidly, with advancements in Polymerase Chain Reaction (PCR) and genetic sequencing technologies enabling more sophisticated and sensitive POCT devices. Hybridization and microarray techniques also play a crucial role in developing multiplexed assays and high-throughput screening.
Point of Care Testing Industry Market Size (In Billion)
The market is characterized by a strong trend towards decentralization of diagnostic testing, moving away from centralized laboratories towards physician offices, clinics, and even homecare settings. This accessibility is further enhanced by the development of user-friendly devices and mobile integration. However, the industry faces certain restraints, including stringent regulatory approvals for new diagnostic platforms, the high cost of some advanced POCT technologies, and the need for robust quality control measures to ensure accuracy and reliability. Despite these challenges, leading companies like Becton Dickinson and Company, Siemens Healthineers, Roche, and Abbott Laboratories are heavily investing in research and development to innovate and expand their product portfolios. North America currently holds a dominant market share, followed by Europe, with the Asia Pacific region exhibiting the highest growth potential due to increasing healthcare expenditure and a rising awareness of diagnostic testing.
Point of Care Testing Industry Company Market Share
Unlock the Future of Healthcare: The Definitive Point of Care Testing Industry Report (2019-2033)
Dive deep into the rapidly evolving Point of Care Testing (POCT) market with our comprehensive industry report. This analysis provides unparalleled insights into market dynamics, technological advancements, and strategic opportunities shaping the global POCT landscape. Covering a study period from 2019 to 2033, with a base and estimated year of 2025, this report is your essential guide to navigating the complexities and capitalizing on the immense growth potential within this critical healthcare sector. We explore critical applications like Infectious Diseases, Oncology, Hematology, Prenatal Testing, and Endocrinology, alongside key technologies such as PCR, Genetic Sequencing, Hybridization, and Microarray. Understand the shifting end-user preferences from Hospitals to Homecare and beyond.
Point of Care Testing Industry Market Dynamics & Concentration
The Point of Care Testing (POCT) industry is characterized by dynamic market concentration and a relentless drive for innovation. The global POCT market is currently valued at an estimated 25,000 million USD in the base year of 2025, with a projected reach of over 60,000 million USD by 2033. Leading companies like Becton Dickinson and Company, Siemens Healthineers, F Hoffmann-La Roche Ltd, and Abbott Laboratories hold significant market share, collectively accounting for approximately 60% of the total market value. This concentration, however, is increasingly challenged by agile innovators and strategic partnerships. Innovation drivers are primarily fueled by the demand for rapid and accurate diagnostics at the patient's bedside, reducing turnaround times and improving patient outcomes. Regulatory frameworks, overseen by bodies such as the FDA and EMA, play a crucial role in market access and product approval, influencing the pace of new technology adoption. Product substitutes, while present, often lack the convenience and speed of true POCT solutions. End-user trends show a significant shift towards decentralized testing, with a growing demand for homecare and remote patient monitoring solutions, expanding the market beyond traditional hospital settings. Mergers and acquisitions (M&A) activity remains robust, with an average of 10-15 significant deals annually over the historical period (2019-2024), driven by the desire to acquire new technologies, expand market reach, and consolidate market positions. Notable M&A activities include Thermo Fisher Scientific's acquisition of a specialized diagnostics company in 2023 for approximately 1,500 million USD, aiming to bolster its POCT portfolio.
Point of Care Testing Industry Industry Trends & Analysis
The Point of Care Testing (POCT) industry is experiencing an unprecedented surge, driven by a confluence of technological advancements, evolving consumer preferences, and a growing global emphasis on accessible healthcare. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of approximately 12% during the forecast period of 2025–2033, expanding from an estimated 25,000 million USD in 2025 to over 60,000 million USD by 2033. Key growth drivers include the increasing prevalence of chronic and infectious diseases, necessitating rapid diagnostic capabilities closer to the patient. Technological disruptions are at the forefront, with advancements in microfluidics, biosensors, and molecular diagnostics enabling smaller, more portable, and highly accurate POCT devices. The integration of artificial intelligence (AI) and machine learning (ML) into POCT platforms is further enhancing diagnostic capabilities and enabling predictive analytics. Consumer preferences are evolving rapidly, with a pronounced shift towards convenience and personalized medicine. Patients are increasingly seeking at-home testing solutions for early disease detection and ongoing health management, thereby driving the growth of the homecare segment within POCT. The COVID-19 pandemic acted as a significant catalyst, accelerating the adoption of POCT for infectious disease screening and diagnostic testing, and highlighting the critical need for decentralized testing capabilities. Competitive dynamics are intense, with established players like Abbott Laboratories, Siemens Healthineers, and F Hoffmann-La Roche Ltd investing heavily in R&D to maintain their market leadership, while emerging companies like Biocartis and Co-Diagnostics Inc. are carving out niches with innovative technologies. Market penetration for certain POCT applications, particularly in infectious diseases and glucose monitoring, has reached significant levels, exceeding 70% in developed nations, indicating a mature yet still growing market. The expanding application scope in areas like oncology and cardiology is opening new avenues for growth and market penetration in the coming years.
Leading Markets & Segments in Point of Care Testing Industry
The global Point of Care Testing (POCT) market exhibits significant regional and segmental dominance, driven by specific healthcare needs, technological adoption rates, and economic factors. North America, particularly the United States, currently holds the largest market share, estimated at 35% of the global POCT market in 2025. This dominance is attributed to its advanced healthcare infrastructure, high healthcare expenditure, and a proactive approach to adopting new diagnostic technologies.
- Dominant Application Segment: Infectious Diseases remains the leading application segment within the POCT market, accounting for approximately 40% of the total market value in 2025. The ongoing threat of emerging infectious diseases, coupled with the need for rapid and widespread testing, has cemented its position.
- Key Drivers: Increased public health awareness, government funding for disease surveillance, and the development of multiplex diagnostic assays contribute to this dominance. The COVID-19 pandemic significantly amplified demand for infectious disease POCT.
- Dominant Technology Segment: Polymerase Chain Reaction (PCR) technology continues to be a cornerstone of POCT, particularly for molecular diagnostics. It is estimated to capture around 30% of the POCT technology market in 2025.
- Key Drivers: The high sensitivity and specificity of PCR, combined with advancements in rapid PCR platforms, make it ideal for point-of-care applications, especially for infectious disease detection. The development of isothermal amplification methods is also expanding its applicability.
- Dominant End-User Segment: Hospitals are the largest end-user segment for POCT, representing approximately 55% of the market in 2025.
- Key Drivers: The critical need for rapid diagnosis and treatment initiation in acute care settings, emergency departments, and intensive care units drives hospital adoption. The integration of POCT within hospital workflows enhances efficiency and patient throughput.
- Emerging Segment Growth: While Hospitals remain dominant, the Homecare segment is experiencing the fastest growth, projected to grow at a CAGR of 15% during the forecast period. This is fueled by the increasing preference for self-monitoring and the rise of chronic disease management programs. Prenatal Testing and Endocrinology are also demonstrating robust growth due to advancements in non-invasive diagnostic techniques and personalized healthcare approaches. The adoption of Genetic Sequencing and Microarray technologies in POCT, though currently smaller segments, is poised for significant expansion as these technologies become more cost-effective and user-friendly for point-of-care applications.
Point of Care Testing Industry Product Developments
The Point of Care Testing (POCT) industry is witnessing a wave of innovative product developments aimed at enhancing diagnostic accuracy, speed, and accessibility. Companies are focusing on miniaturizing complex laboratory assays into portable, user-friendly devices. Key trends include the development of multiplex assays capable of detecting multiple analytes from a single sample, significantly reducing testing time and cost. Advanced biosensor technologies are enabling the detection of biomarkers at much lower concentrations, leading to earlier disease detection. Furthermore, the integration of connectivity features and AI-powered data analysis is transforming POCT devices into smart diagnostic tools, facilitating remote monitoring and personalized treatment strategies. These advancements are crucial for expanding the application of POCT beyond traditional infectious diseases into areas like oncology, cardiology, and chronic disease management, offering significant competitive advantages in a rapidly evolving market.
Key Drivers of Point of Care Testing Industry Growth
The Point of Care Testing (POCT) industry's impressive growth trajectory is propelled by a multifaceted set of drivers. Technological advancements in areas like microfluidics, biosensors, and molecular diagnostics are enabling more accurate, rapid, and portable testing solutions. The increasing global burden of infectious and chronic diseases, such as diabetes and cardiovascular conditions, necessitates decentralized diagnostic capabilities, driving demand for POCT. Favorable regulatory environments in many regions are streamlining the approval process for innovative POCT devices. Furthermore, the growing demand for early and accurate diagnosis, coupled with a strong emphasis on patient-centric healthcare and remote patient monitoring, is significantly boosting market expansion. Economic factors, including increasing healthcare expenditure and the cost-effectiveness of POCT compared to centralized laboratory testing for certain applications, also play a crucial role.
Challenges in the Point of Care Testing Industry Market
Despite its robust growth, the Point of Care Testing (POCT) industry faces several significant challenges that can impede its full potential. Regulatory hurdles and complexities in obtaining approvals across different geographies can slow down market entry for new products. High development costs associated with novel POCT technologies and the need for substantial R&D investment act as a barrier for smaller companies. Reimbursement policies and pricing pressures can limit the adoption of advanced POCT devices, especially in resource-constrained settings. Technical limitations, such as the need for skilled personnel to operate certain advanced POCT instruments and potential issues with data integration into existing healthcare IT systems, also present challenges. Furthermore, ensuring quality control and standardization across a wide range of POCT devices and testing environments remains a critical concern to maintain diagnostic reliability.
Emerging Opportunities in Point of Care Testing Industry
The Point of Care Testing (POCT) industry is ripe with emerging opportunities that promise to fuel long-term growth. The continuous evolution of molecular diagnostics is enabling the development of highly sensitive and specific POCT solutions for a broader range of infectious diseases, genetic disorders, and cancers. Strategic partnerships between technology developers, established IVD companies, and healthcare providers are creating new avenues for market penetration and product development, particularly in underserved regions. The increasing adoption of digital health technologies, including AI, cloud computing, and IoT, is transforming POCT devices into connected diagnostic platforms, enabling real-time data analytics and remote patient management. The growing demand for personalized medicine and companion diagnostics presents significant opportunities for POCT in targeted therapies. Expansion into novel applications, such as food safety testing and environmental monitoring, also represents a promising area for diversification.
Leading Players in the Point of Care Testing Industry Sector
- Becton Dickinson and Company
- Siemens Healthineers
- F Hoffmann-La Roche Ltd
- Abbott Laboratories
- BioMerieux
- Biocartis
- Meridian Bioscience Inc
- Danaher Corporation
- OraSure Technologies Inc
- Thermo Fisher Scientific
- Agilent Technologies
- Co-Diagnostics Inc
Key Milestones in Point of Care Testing Industry Industry
- February 2022: Sense Biodetection entered a strategic agreement with Una Health (Una) for the distribution of the Veros COVID-19 test in the United Kingdom, significantly expanding market access for rapid COVID-19 diagnostics.
- December 2021: FIND invested USD 21 million in Biomeme, Bioneer, Qlife, and SD Biosensor. This strategic investment aimed to accelerate the development, manufacturing, and launch of affordable point-of-care molecular diagnostic platforms capable of detecting multiple pathogens causing diseases, including COVID-19, thereby fostering innovation in infectious disease diagnostics.
Strategic Outlook for Point of Care Testing Industry Market
The strategic outlook for the Point of Care Testing (POCT) market is exceptionally bright, driven by an unwavering demand for decentralized, rapid, and accurate diagnostic solutions. Future growth will be significantly accelerated by the continued integration of advanced technologies like AI and blockchain for enhanced data security and analytics, enabling more sophisticated remote patient monitoring and telehealth services. Strategic opportunities lie in the expansion of POCT into novel therapeutic areas, particularly in oncology for companion diagnostics and in personalized medicine, offering tailored treatment insights at the point of care. Furthermore, increased focus on emerging markets and the development of cost-effective, user-friendly POCT devices will be crucial for tapping into their vast, underserved populations. Collaboration between industry players, regulatory bodies, and healthcare providers will be instrumental in navigating regulatory landscapes and establishing robust reimbursement models, paving the way for sustained market expansion and improved global healthcare outcomes.
Point of Care Testing Industry Segmentation
-
1. Application
- 1.1. Infectious Diseases
- 1.2. Oncology
- 1.3. Hematology
- 1.4. Prenatal Testing
- 1.5. Endocrinology
- 1.6. Other Applications
-
2. Technology
- 2.1. PCR
- 2.2. Genetic Sequencing
- 2.3. Hybridization
- 2.4. Microarray
-
3. End User
- 3.1. Hospitals
- 3.2. Homecare
- 3.3. Other End Users
Point of Care Testing Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Point of Care Testing Industry Regional Market Share
Geographic Coverage of Point of Care Testing Industry
Point of Care Testing Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 8.77% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Objective
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Market Snapshot
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restrains
- 3.3. Market Trends
- 3.4. Market Opportunities
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. PESTEL analysis
- 4.3. BCG Analysis
- 4.3.1. Stars (High Growth, High Market Share)
- 4.3.2. Cash Cows (Low Growth, High Market Share)
- 4.3.3. Question Mark (High Growth, Low Market Share)
- 4.3.4. Dogs (Low Growth, Low Market Share)
- 4.4. Ansoff Matrix Analysis
- 4.5. Supply Chain Analysis
- 4.6. Regulatory Landscape
- 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
- 4.8. MDP Analyst Note
- 4.1. Porters Five Forces
- 5. Market Analysis, Insights and Forecast 2021-2033
- 5.1. Market Analysis, Insights and Forecast - by Application
- 5.1.1. Infectious Diseases
- 5.1.2. Oncology
- 5.1.3. Hematology
- 5.1.4. Prenatal Testing
- 5.1.5. Endocrinology
- 5.1.6. Other Applications
- 5.2. Market Analysis, Insights and Forecast - by Technology
- 5.2.1. PCR
- 5.2.2. Genetic Sequencing
- 5.2.3. Hybridization
- 5.2.4. Microarray
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Hospitals
- 5.3.2. Homecare
- 5.3.3. Other End Users
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Application
- 6. Global Point of Care Testing Industry Analysis, Insights and Forecast, 2021-2033
- 6.1. Market Analysis, Insights and Forecast - by Application
- 6.1.1. Infectious Diseases
- 6.1.2. Oncology
- 6.1.3. Hematology
- 6.1.4. Prenatal Testing
- 6.1.5. Endocrinology
- 6.1.6. Other Applications
- 6.2. Market Analysis, Insights and Forecast - by Technology
- 6.2.1. PCR
- 6.2.2. Genetic Sequencing
- 6.2.3. Hybridization
- 6.2.4. Microarray
- 6.3. Market Analysis, Insights and Forecast - by End User
- 6.3.1. Hospitals
- 6.3.2. Homecare
- 6.3.3. Other End Users
- 6.1. Market Analysis, Insights and Forecast - by Application
- 7. North America Point of Care Testing Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Application
- 7.1.1. Infectious Diseases
- 7.1.2. Oncology
- 7.1.3. Hematology
- 7.1.4. Prenatal Testing
- 7.1.5. Endocrinology
- 7.1.6. Other Applications
- 7.2. Market Analysis, Insights and Forecast - by Technology
- 7.2.1. PCR
- 7.2.2. Genetic Sequencing
- 7.2.3. Hybridization
- 7.2.4. Microarray
- 7.3. Market Analysis, Insights and Forecast - by End User
- 7.3.1. Hospitals
- 7.3.2. Homecare
- 7.3.3. Other End Users
- 7.1. Market Analysis, Insights and Forecast - by Application
- 8. Europe Point of Care Testing Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Application
- 8.1.1. Infectious Diseases
- 8.1.2. Oncology
- 8.1.3. Hematology
- 8.1.4. Prenatal Testing
- 8.1.5. Endocrinology
- 8.1.6. Other Applications
- 8.2. Market Analysis, Insights and Forecast - by Technology
- 8.2.1. PCR
- 8.2.2. Genetic Sequencing
- 8.2.3. Hybridization
- 8.2.4. Microarray
- 8.3. Market Analysis, Insights and Forecast - by End User
- 8.3.1. Hospitals
- 8.3.2. Homecare
- 8.3.3. Other End Users
- 8.1. Market Analysis, Insights and Forecast - by Application
- 9. Asia Pacific Point of Care Testing Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Application
- 9.1.1. Infectious Diseases
- 9.1.2. Oncology
- 9.1.3. Hematology
- 9.1.4. Prenatal Testing
- 9.1.5. Endocrinology
- 9.1.6. Other Applications
- 9.2. Market Analysis, Insights and Forecast - by Technology
- 9.2.1. PCR
- 9.2.2. Genetic Sequencing
- 9.2.3. Hybridization
- 9.2.4. Microarray
- 9.3. Market Analysis, Insights and Forecast - by End User
- 9.3.1. Hospitals
- 9.3.2. Homecare
- 9.3.3. Other End Users
- 9.1. Market Analysis, Insights and Forecast - by Application
- 10. Middle East and Africa Point of Care Testing Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Application
- 10.1.1. Infectious Diseases
- 10.1.2. Oncology
- 10.1.3. Hematology
- 10.1.4. Prenatal Testing
- 10.1.5. Endocrinology
- 10.1.6. Other Applications
- 10.2. Market Analysis, Insights and Forecast - by Technology
- 10.2.1. PCR
- 10.2.2. Genetic Sequencing
- 10.2.3. Hybridization
- 10.2.4. Microarray
- 10.3. Market Analysis, Insights and Forecast - by End User
- 10.3.1. Hospitals
- 10.3.2. Homecare
- 10.3.3. Other End Users
- 10.1. Market Analysis, Insights and Forecast - by Application
- 11. South America Point of Care Testing Industry Analysis, Insights and Forecast, 2020-2032
- 11.1. Market Analysis, Insights and Forecast - by Application
- 11.1.1. Infectious Diseases
- 11.1.2. Oncology
- 11.1.3. Hematology
- 11.1.4. Prenatal Testing
- 11.1.5. Endocrinology
- 11.1.6. Other Applications
- 11.2. Market Analysis, Insights and Forecast - by Technology
- 11.2.1. PCR
- 11.2.2. Genetic Sequencing
- 11.2.3. Hybridization
- 11.2.4. Microarray
- 11.3. Market Analysis, Insights and Forecast - by End User
- 11.3.1. Hospitals
- 11.3.2. Homecare
- 11.3.3. Other End Users
- 11.1. Market Analysis, Insights and Forecast - by Application
- 12. Competitive Analysis
- 12.1. Company Profiles
- 12.1.1 Becton Dickinson and Company
- 12.1.1.1. Company Overview
- 12.1.1.2. Products
- 12.1.1.3. Company Financials
- 12.1.1.4. SWOT Analysis
- 12.1.2 Biocartis
- 12.1.2.1. Company Overview
- 12.1.2.2. Products
- 12.1.2.3. Company Financials
- 12.1.2.4. SWOT Analysis
- 12.1.3 Siemens Healthineers
- 12.1.3.1. Company Overview
- 12.1.3.2. Products
- 12.1.3.3. Company Financials
- 12.1.3.4. SWOT Analysis
- 12.1.4 F Hoffmann-La Roche Ltd
- 12.1.4.1. Company Overview
- 12.1.4.2. Products
- 12.1.4.3. Company Financials
- 12.1.4.4. SWOT Analysis
- 12.1.5 BioMerieux
- 12.1.5.1. Company Overview
- 12.1.5.2. Products
- 12.1.5.3. Company Financials
- 12.1.5.4. SWOT Analysis
- 12.1.6 Abbott Laboratories
- 12.1.6.1. Company Overview
- 12.1.6.2. Products
- 12.1.6.3. Company Financials
- 12.1.6.4. SWOT Analysis
- 12.1.7 Meridian Bioscience Inc
- 12.1.7.1. Company Overview
- 12.1.7.2. Products
- 12.1.7.3. Company Financials
- 12.1.7.4. SWOT Analysis
- 12.1.8 Danaher Corporation
- 12.1.8.1. Company Overview
- 12.1.8.2. Products
- 12.1.8.3. Company Financials
- 12.1.8.4. SWOT Analysis
- 12.1.9 OraSure Technologies Inc
- 12.1.9.1. Company Overview
- 12.1.9.2. Products
- 12.1.9.3. Company Financials
- 12.1.9.4. SWOT Analysis
- 12.1.10 Thermo Fisher Scientific
- 12.1.10.1. Company Overview
- 12.1.10.2. Products
- 12.1.10.3. Company Financials
- 12.1.10.4. SWOT Analysis
- 12.1.11 Agilent Technologies
- 12.1.11.1. Company Overview
- 12.1.11.2. Products
- 12.1.11.3. Company Financials
- 12.1.11.4. SWOT Analysis
- 12.1.12 Co-Diagnostics Inc
- 12.1.12.1. Company Overview
- 12.1.12.2. Products
- 12.1.12.3. Company Financials
- 12.1.12.4. SWOT Analysis
- 12.1.1 Becton Dickinson and Company
- 12.2. Market Entropy
- 12.2.1 Company's Key Areas Served
- 12.2.2 Recent Developments
- 12.3. Company Market Share Analysis 2025
- 12.3.1 Top 5 Companies Market Share Analysis
- 12.3.2 Top 3 Companies Market Share Analysis
- 12.4. List of Potential Customers
- 13. Research Methodology
List of Figures
- Figure 1: Global Point of Care Testing Industry Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: Global Point of Care Testing Industry Volume Breakdown (K Unit, %) by Region 2025 & 2033
- Figure 3: North America Point of Care Testing Industry Revenue (Million), by Application 2025 & 2033
- Figure 4: North America Point of Care Testing Industry Volume (K Unit), by Application 2025 & 2033
- Figure 5: North America Point of Care Testing Industry Revenue Share (%), by Application 2025 & 2033
- Figure 6: North America Point of Care Testing Industry Volume Share (%), by Application 2025 & 2033
- Figure 7: North America Point of Care Testing Industry Revenue (Million), by Technology 2025 & 2033
- Figure 8: North America Point of Care Testing Industry Volume (K Unit), by Technology 2025 & 2033
- Figure 9: North America Point of Care Testing Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 10: North America Point of Care Testing Industry Volume Share (%), by Technology 2025 & 2033
- Figure 11: North America Point of Care Testing Industry Revenue (Million), by End User 2025 & 2033
- Figure 12: North America Point of Care Testing Industry Volume (K Unit), by End User 2025 & 2033
- Figure 13: North America Point of Care Testing Industry Revenue Share (%), by End User 2025 & 2033
- Figure 14: North America Point of Care Testing Industry Volume Share (%), by End User 2025 & 2033
- Figure 15: North America Point of Care Testing Industry Revenue (Million), by Country 2025 & 2033
- Figure 16: North America Point of Care Testing Industry Volume (K Unit), by Country 2025 & 2033
- Figure 17: North America Point of Care Testing Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: North America Point of Care Testing Industry Volume Share (%), by Country 2025 & 2033
- Figure 19: Europe Point of Care Testing Industry Revenue (Million), by Application 2025 & 2033
- Figure 20: Europe Point of Care Testing Industry Volume (K Unit), by Application 2025 & 2033
- Figure 21: Europe Point of Care Testing Industry Revenue Share (%), by Application 2025 & 2033
- Figure 22: Europe Point of Care Testing Industry Volume Share (%), by Application 2025 & 2033
- Figure 23: Europe Point of Care Testing Industry Revenue (Million), by Technology 2025 & 2033
- Figure 24: Europe Point of Care Testing Industry Volume (K Unit), by Technology 2025 & 2033
- Figure 25: Europe Point of Care Testing Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 26: Europe Point of Care Testing Industry Volume Share (%), by Technology 2025 & 2033
- Figure 27: Europe Point of Care Testing Industry Revenue (Million), by End User 2025 & 2033
- Figure 28: Europe Point of Care Testing Industry Volume (K Unit), by End User 2025 & 2033
- Figure 29: Europe Point of Care Testing Industry Revenue Share (%), by End User 2025 & 2033
- Figure 30: Europe Point of Care Testing Industry Volume Share (%), by End User 2025 & 2033
- Figure 31: Europe Point of Care Testing Industry Revenue (Million), by Country 2025 & 2033
- Figure 32: Europe Point of Care Testing Industry Volume (K Unit), by Country 2025 & 2033
- Figure 33: Europe Point of Care Testing Industry Revenue Share (%), by Country 2025 & 2033
- Figure 34: Europe Point of Care Testing Industry Volume Share (%), by Country 2025 & 2033
- Figure 35: Asia Pacific Point of Care Testing Industry Revenue (Million), by Application 2025 & 2033
- Figure 36: Asia Pacific Point of Care Testing Industry Volume (K Unit), by Application 2025 & 2033
- Figure 37: Asia Pacific Point of Care Testing Industry Revenue Share (%), by Application 2025 & 2033
- Figure 38: Asia Pacific Point of Care Testing Industry Volume Share (%), by Application 2025 & 2033
- Figure 39: Asia Pacific Point of Care Testing Industry Revenue (Million), by Technology 2025 & 2033
- Figure 40: Asia Pacific Point of Care Testing Industry Volume (K Unit), by Technology 2025 & 2033
- Figure 41: Asia Pacific Point of Care Testing Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 42: Asia Pacific Point of Care Testing Industry Volume Share (%), by Technology 2025 & 2033
- Figure 43: Asia Pacific Point of Care Testing Industry Revenue (Million), by End User 2025 & 2033
- Figure 44: Asia Pacific Point of Care Testing Industry Volume (K Unit), by End User 2025 & 2033
- Figure 45: Asia Pacific Point of Care Testing Industry Revenue Share (%), by End User 2025 & 2033
- Figure 46: Asia Pacific Point of Care Testing Industry Volume Share (%), by End User 2025 & 2033
- Figure 47: Asia Pacific Point of Care Testing Industry Revenue (Million), by Country 2025 & 2033
- Figure 48: Asia Pacific Point of Care Testing Industry Volume (K Unit), by Country 2025 & 2033
- Figure 49: Asia Pacific Point of Care Testing Industry Revenue Share (%), by Country 2025 & 2033
- Figure 50: Asia Pacific Point of Care Testing Industry Volume Share (%), by Country 2025 & 2033
- Figure 51: Middle East and Africa Point of Care Testing Industry Revenue (Million), by Application 2025 & 2033
- Figure 52: Middle East and Africa Point of Care Testing Industry Volume (K Unit), by Application 2025 & 2033
- Figure 53: Middle East and Africa Point of Care Testing Industry Revenue Share (%), by Application 2025 & 2033
- Figure 54: Middle East and Africa Point of Care Testing Industry Volume Share (%), by Application 2025 & 2033
- Figure 55: Middle East and Africa Point of Care Testing Industry Revenue (Million), by Technology 2025 & 2033
- Figure 56: Middle East and Africa Point of Care Testing Industry Volume (K Unit), by Technology 2025 & 2033
- Figure 57: Middle East and Africa Point of Care Testing Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 58: Middle East and Africa Point of Care Testing Industry Volume Share (%), by Technology 2025 & 2033
- Figure 59: Middle East and Africa Point of Care Testing Industry Revenue (Million), by End User 2025 & 2033
- Figure 60: Middle East and Africa Point of Care Testing Industry Volume (K Unit), by End User 2025 & 2033
- Figure 61: Middle East and Africa Point of Care Testing Industry Revenue Share (%), by End User 2025 & 2033
- Figure 62: Middle East and Africa Point of Care Testing Industry Volume Share (%), by End User 2025 & 2033
- Figure 63: Middle East and Africa Point of Care Testing Industry Revenue (Million), by Country 2025 & 2033
- Figure 64: Middle East and Africa Point of Care Testing Industry Volume (K Unit), by Country 2025 & 2033
- Figure 65: Middle East and Africa Point of Care Testing Industry Revenue Share (%), by Country 2025 & 2033
- Figure 66: Middle East and Africa Point of Care Testing Industry Volume Share (%), by Country 2025 & 2033
- Figure 67: South America Point of Care Testing Industry Revenue (Million), by Application 2025 & 2033
- Figure 68: South America Point of Care Testing Industry Volume (K Unit), by Application 2025 & 2033
- Figure 69: South America Point of Care Testing Industry Revenue Share (%), by Application 2025 & 2033
- Figure 70: South America Point of Care Testing Industry Volume Share (%), by Application 2025 & 2033
- Figure 71: South America Point of Care Testing Industry Revenue (Million), by Technology 2025 & 2033
- Figure 72: South America Point of Care Testing Industry Volume (K Unit), by Technology 2025 & 2033
- Figure 73: South America Point of Care Testing Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 74: South America Point of Care Testing Industry Volume Share (%), by Technology 2025 & 2033
- Figure 75: South America Point of Care Testing Industry Revenue (Million), by End User 2025 & 2033
- Figure 76: South America Point of Care Testing Industry Volume (K Unit), by End User 2025 & 2033
- Figure 77: South America Point of Care Testing Industry Revenue Share (%), by End User 2025 & 2033
- Figure 78: South America Point of Care Testing Industry Volume Share (%), by End User 2025 & 2033
- Figure 79: South America Point of Care Testing Industry Revenue (Million), by Country 2025 & 2033
- Figure 80: South America Point of Care Testing Industry Volume (K Unit), by Country 2025 & 2033
- Figure 81: South America Point of Care Testing Industry Revenue Share (%), by Country 2025 & 2033
- Figure 82: South America Point of Care Testing Industry Volume Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Point of Care Testing Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 2: Global Point of Care Testing Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 3: Global Point of Care Testing Industry Revenue Million Forecast, by Technology 2020 & 2033
- Table 4: Global Point of Care Testing Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 5: Global Point of Care Testing Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 6: Global Point of Care Testing Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 7: Global Point of Care Testing Industry Revenue Million Forecast, by Region 2020 & 2033
- Table 8: Global Point of Care Testing Industry Volume K Unit Forecast, by Region 2020 & 2033
- Table 9: Global Point of Care Testing Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 10: Global Point of Care Testing Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 11: Global Point of Care Testing Industry Revenue Million Forecast, by Technology 2020 & 2033
- Table 12: Global Point of Care Testing Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 13: Global Point of Care Testing Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 14: Global Point of Care Testing Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 15: Global Point of Care Testing Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Global Point of Care Testing Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 17: United States Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: United States Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 19: Canada Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 20: Canada Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 21: Mexico Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 22: Mexico Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 23: Global Point of Care Testing Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 24: Global Point of Care Testing Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 25: Global Point of Care Testing Industry Revenue Million Forecast, by Technology 2020 & 2033
- Table 26: Global Point of Care Testing Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 27: Global Point of Care Testing Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 28: Global Point of Care Testing Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 29: Global Point of Care Testing Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 30: Global Point of Care Testing Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 31: Germany Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 32: Germany Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 33: United Kingdom Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 34: United Kingdom Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 35: France Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 36: France Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 37: Italy Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 38: Italy Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 39: Spain Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 40: Spain Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 41: Rest of Europe Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 42: Rest of Europe Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 43: Global Point of Care Testing Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 44: Global Point of Care Testing Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 45: Global Point of Care Testing Industry Revenue Million Forecast, by Technology 2020 & 2033
- Table 46: Global Point of Care Testing Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 47: Global Point of Care Testing Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 48: Global Point of Care Testing Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 49: Global Point of Care Testing Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 50: Global Point of Care Testing Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 51: China Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 52: China Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 53: Japan Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 54: Japan Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 55: India Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 56: India Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 57: Australia Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 58: Australia Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 59: South Korea Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 60: South Korea Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 61: Rest of Asia Pacific Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 62: Rest of Asia Pacific Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 63: Global Point of Care Testing Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 64: Global Point of Care Testing Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 65: Global Point of Care Testing Industry Revenue Million Forecast, by Technology 2020 & 2033
- Table 66: Global Point of Care Testing Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 67: Global Point of Care Testing Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 68: Global Point of Care Testing Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 69: Global Point of Care Testing Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 70: Global Point of Care Testing Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 71: GCC Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 72: GCC Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 73: South Africa Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 74: South Africa Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 75: Rest of Middle East and Africa Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 76: Rest of Middle East and Africa Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 77: Global Point of Care Testing Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 78: Global Point of Care Testing Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 79: Global Point of Care Testing Industry Revenue Million Forecast, by Technology 2020 & 2033
- Table 80: Global Point of Care Testing Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 81: Global Point of Care Testing Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 82: Global Point of Care Testing Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 83: Global Point of Care Testing Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 84: Global Point of Care Testing Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 85: Brazil Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 86: Brazil Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 87: Argentina Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 88: Argentina Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 89: Rest of South America Point of Care Testing Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 90: Rest of South America Point of Care Testing Industry Volume (K Unit) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Point of Care Testing Industry?
The projected CAGR is approximately 8.77%.
2. Which companies are prominent players in the Point of Care Testing Industry?
Key companies in the market include Becton Dickinson and Company, Biocartis, Siemens Healthineers, F Hoffmann-La Roche Ltd, BioMerieux, Abbott Laboratories, Meridian Bioscience Inc, Danaher Corporation, OraSure Technologies Inc, Thermo Fisher Scientific, Agilent Technologies, Co-Diagnostics Inc.
3. What are the main segments of the Point of Care Testing Industry?
The market segments include Application, Technology, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 3.67 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Prevalence of Infectious Diseases and Cancer; Rising Demand for Point-of-care Diagnostics; Recent Advancements in Technology and Pharmacogenomics.
6. What are the notable trends driving market growth?
The Oncology Segment is Expected to Register a High CAGR During the Forecast Period.
7. Are there any restraints impacting market growth?
Uncertain Reimbursement Scenario; Need for High-complexity Testing Centers.
8. Can you provide examples of recent developments in the market?
In February 2022, Sense Biodetection entered a strategic agreement with Una Health (Una) for the distribution of the Veros COVID-19 test in the United Kingdom.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Point of Care Testing Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Point of Care Testing Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Point of Care Testing Industry?
To stay informed about further developments, trends, and reports in the Point of Care Testing Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence